These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 34903768

  • 1. Determining chromosomal arms 1p/19q co-deletion status in low graded glioma by cross correlation-periodogram pattern analysis.
    Bhattacharya D, Sinha N, Saini J.
    Sci Rep; 2021 Dec 13; 11(1):23866. PubMed ID: 34903768
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 18F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma.
    Cicone F, Carideo L, Scaringi C, Arcella A, Giangaspero F, Scopinaro F, Minniti G.
    Ann Nucl Med; 2019 Apr 13; 33(4):295-302. PubMed ID: 30607877
    [Abstract] [Full Text] [Related]

  • 4. Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.
    Han Y, Xie Z, Zang Y, Zhang S, Gu D, Zhou M, Gevaert O, Wei J, Li C, Chen H, Du J, Liu Z, Dong D, Tian J, Zhou D.
    J Neurooncol; 2018 Nov 13; 140(2):297-306. PubMed ID: 30097822
    [Abstract] [Full Text] [Related]

  • 5. Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence.
    Akkus Z, Ali I, Sedlář J, Agrawal JP, Parney IF, Giannini C, Erickson BJ.
    J Digit Imaging; 2017 Aug 13; 30(4):469-476. PubMed ID: 28600641
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm.
    van der Voort SR, Incekara F, Wijnenga MMJ, Kapas G, Gardeniers M, Schouten JW, Starmans MPA, Nandoe Tewarie R, Lycklama GJ, French PJ, Dubbink HJ, van den Bent MJ, Vincent AJPE, Niessen WJ, Klein S, Smits M.
    Clin Cancer Res; 2019 Dec 15; 25(24):7455-7462. PubMed ID: 31548344
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of chromosome 1p/19q deletion by Fluorescence in Situ Hybridization (FISH) as prognostic factors in malignant glioma patients on treatment with alkylating chemotherapy.
    Pandith AA, Zahoor W, Manzoor U, Nisar S, Guru FR, Naikoo NA, Aein QU, Baba SM, Bhat AR, Ganai F, Shah P.
    Cancer Genet; 2023 Nov 15; 278-279():55-61. PubMed ID: 37625215
    [Abstract] [Full Text] [Related]

  • 10. Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.
    Verger A, Stoffels G, Bauer EK, Lohmann P, Blau T, Fink GR, Neumaier B, Shah NJ, Langen KJ, Galldiks N.
    Eur J Nucl Med Mol Imaging; 2018 Mar 15; 45(3):443-451. PubMed ID: 29043400
    [Abstract] [Full Text] [Related]

  • 11. Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas.
    Park YW, Han K, Ahn SS, Bae S, Choi YS, Chang JH, Kim SH, Kang SG, Lee SK.
    AJNR Am J Neuroradiol; 2018 Jan 15; 39(1):37-42. PubMed ID: 29122763
    [Abstract] [Full Text] [Related]

  • 12. Loss of genetic material within 1p and 19q chromosomal arms in low grade gliomas of central nervous system.
    Ręcławowicz D, Stempniewicz M, Biernat W, Limon J, Słoniewski P.
    Folia Neuropathol; 2013 Jan 15; 51(1):26-32. PubMed ID: 23553134
    [Abstract] [Full Text] [Related]

  • 13. Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study.
    Yao J, Hagiwara A, Raymond C, Shabani S, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM.
    Sci Rep; 2020 Jul 17; 10(1):11922. PubMed ID: 32681084
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A, Yolcu YU, Goyal A, Kerezoudis P, Brown DA, Graffeo CS, Goncalves S, Burns TC, Parney IF.
    Neurosurg Focus; 2019 Dec 01; 47(6):E13. PubMed ID: 31786548
    [Abstract] [Full Text] [Related]

  • 16. Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.
    Yamauchi T, Ohno M, Matsushita Y, Takahashi M, Miyakita Y, Kitagawa Y, Kondo E, Tsushita N, Satomi K, Yoshida A, Ichimura K, Narita Y.
    Brain Tumor Pathol; 2018 Jul 01; 35(3):148-158. PubMed ID: 29922974
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.
    Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, Pöpperl G, Kretzschmar HA, Cumming P, Bartenstein P, Tonn JC, Kreth FW, la Fougère C, Thon N.
    Neuro Oncol; 2012 Dec 01; 14(12):1473-80. PubMed ID: 23090986
    [Abstract] [Full Text] [Related]

  • 20. Predicting 1p/19q co-deletion status from magnetic resonance imaging using deep learning in adult-type diffuse lower-grade gliomas: a discovery and validation study.
    Yan J, Zhang S, Sun Q, Wang W, Duan W, Wang L, Ding T, Pei D, Sun C, Wang W, Liu Z, Hong X, Wang X, Guo Y, Li W, Cheng J, Liu X, Li ZC, Zhang Z.
    Lab Invest; 2022 Feb 01; 102(2):154-159. PubMed ID: 34782727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.